Controlling Health Care Costs Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier? Issue Briefs / Oct 05, 2017
Controlling Health Care Costs The Case for Drug-Pricing Reform — The Cost of Inaction blog / May 26, 2021
Controlling Health Care Costs External Reference Pricing: The Drug-Pricing Reform America Needs? Issue Briefs / May 27, 2021
Controlling Health Care Costs How Federal Drug-Pricing Proposals Could Affect Medicaid blog / Aug 19, 2021
Controlling Health Care Costs Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs blog / Aug 18, 2021
Controlling Health Care Costs Are Pharmacy Benefit Managers the Next Target for Prescription Drug Reform? Blog / Apr 20, 2022
Controlling Health Care Costs Oregon Seeks to Limit Medicaid Coverage of Accelerated-Approval Drugs Blog / Apr 05, 2022
Controlling Health Care Costs Generic Drugs Help Hold Down Costs, But Slowdowns in Development and Review Present Challenges Blog / Mar 24, 2022
Controlling Health Care Costs It’s the Patents, Stupid — Why Drugs Cost So Much in the U.S. Podcast / Feb 25, 2022
Controlling Health Care Costs State Strategies for Slowing Health Care Cost Growth in the Commercial Market Issue Briefs / Feb 24, 2022
Improving Health Care Quality Medicare’s Decision to Cover the Alzheimer’s Drug Aduhelm: What Will It Mean for Patients and the Program? Blog / Jan 19, 2022
Achieving Universal Coverage History in the Balance: The Promise of Build Back Better Blog / Jan 12, 2022
Controlling Health Care Costs Brand-Name Drug Prices: The Key Driver of High Pharmaceutical Spending in the U.S. Publication / Nov 17, 2021
Controlling Health Care Costs Supreme Court Will Determine Whether 340B Hospitals Retain Discounts on Medicare Part B Drugs Blog / Nov 11, 2021
Controlling Health Care Costs Domestic Reference Pricing and Its Potential Role in Medicare Pharmaceutical Price Negotiations Explainer / Oct 26, 2021
Controlling Health Care Costs Skinny Labeling: A Pathway for Timely Generic Drug Competition Blog / Oct 19, 2021